GeoVax Labs Inc. (GOVX)
GOVX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.2656
-5.92% on the day
Market cap
$2.7M
Nano cap
Revenue · 2025
$2.5M
No prior year to compare
Net income · 2025
-$21.5M
-862.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/0001437749-26-012377-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | GOVX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000832489 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.5M |
| Net income | -$21.5M |
| Operating income | -$21.6M |
| Net margin | -862.3% |
| Operating margin | -869.3% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $3.1M |
| Total assets | $6.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-1 | S-1 | 2026-09-17 |
| Latest annual report FORM 10-K | 10-K | 2026-04-15 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-07-27 |
| Latest current report FORM 8-K | 8-K | 2026-09-10 |
| Latest proxy FORM DEF 14A | DEF 14A | 2026-09-10 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| KAPA | Kairos Pharma Ltd. | $0.8287 | -0.40% | $2.8M |
| HCWB | HCW Biologics Inc. | $1.26 | -14.87% | $2.8M |
| MBIO | Mustang Bio Inc. | $0.3768 | -8.63% | $2.9M |
| PRFX | PRF Technologies Ltd. | $0.8180 | -4.88% | $2.9M |
| ONCO | Onconetix Inc. | $0.5550 | -6.00% | $2.9M |
| MTNB | Matinas Biopharma Holdings Inc. | $2.50 | -8.76% | $2.4M |
| DCOY | Decoy Therapeutics Inc. | $1.24 | -13.29% | $3.0M |
| ELAB | PMGC Holdings Inc. | $2.96 | -2.95% | $2.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier